Evonik Industries (FRA:EVK) received a €36.00 ($41.86) price target from stock analysts at Warburg Research in a research note issued to investors on Friday, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the stock. Warburg Research’s price target indicates a potential upside of 38.30% from the stock’s previous close.
A number of other research analysts have also recently commented on EVK. Nord/LB set a €24.00 ($27.91) target price on shares of Evonik Industries and gave the stock a “neutral” rating in a report on Tuesday, November 5th. HSBC set a €25.00 ($29.07) price objective on Evonik Industries and gave the company a “neutral” rating in a research note on Wednesday, September 18th. DZ Bank reaffirmed a “buy” rating on shares of Evonik Industries in a research note on Wednesday, November 6th. Deutsche Bank set a €38.00 ($44.19) price objective on Evonik Industries and gave the company a “buy” rating in a research note on Thursday, October 3rd. Finally, Baader Bank set a €29.00 ($33.72) price objective on Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, November 5th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of €28.14 ($32.73).
Shares of EVK stock traded up €0.20 ($0.23) on Friday, reaching €26.03 ($30.27). The company had a trading volume of 620,387 shares. Evonik Industries has a one year low of €26.78 ($31.14) and a one year high of €32.97 ($38.34). The business’s 50-day moving average is €23.74 and its 200 day moving average is €24.29.
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Recommended Story: Market Indexes
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.